The use of mistletoe in cancer is a popular treatment in cancer in many European countries. The common use is by injection given under the skin and there is a growing interest in the intravenous application. I would classify mistletoe as an original “immune-system” treatment that has finally become to the attention of the mainstream oncology community. Clinically we have seen patients with cancer respond to this form of treatment by improving quality of life symptoms such as in pain, appetite, and energy. Furthermore, there are groups where we have documented a cancer-fighting effect. The first patient we personally treated over 10 years ago was with advanced and progressing colon cancer, where the intravenous application of mistletoe stabilized his disease outside of any chemotherapy treatment. This experience opened our minds to the capabilities of this promising therapy.
The below recent study discusses the application and experience of mistletoe given by intravenous treatment to patients with cancer by a group of European physicians. Positive benefits were noted which included cases of patients whose disease was better controlled and more.
To find out more, please follow the below link.
Intravenous Mistletoe Treatment In Integrative Cancer Care 2016
Discuss what this means for you
Research can raise useful questions. A study or individual case report does not establish that a treatment is suitable for everyone. Discuss medications, supplements and treatment changes with your care team.
Talk with our team